120 related articles for article (PubMed ID: 37919558)
1. Risk factors of developing contralateral breast cancer after first primary breast cancer treatment.
Avatefi M; HadavandSiri F; Nazari SSH; Akbari ME
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1927. PubMed ID: 37919558
[TBL] [Abstract][Full Text] [Related]
2. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
Yoon TI; Kwak BS; Yi OV; Kim S; Um E; Yun KW; Shin HN; Lee S; Sohn G; Chung IY; Kim J; Ko BS; Lee JW; Son BH; Ahn SH; Kim HJ
Breast Cancer Res Treat; 2019 Feb; 173(3):657-665. PubMed ID: 30377870
[TBL] [Abstract][Full Text] [Related]
3. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
[TBL] [Abstract][Full Text] [Related]
5. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
Gao X; Fisher SG; Emami B
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
[TBL] [Abstract][Full Text] [Related]
6. Second primary in the contralateral breast after treatment of breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor RK
Radiother Oncol; 2008 Feb; 86(2):171-6. PubMed ID: 17961777
[TBL] [Abstract][Full Text] [Related]
7. Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.
Akdeniz D; Kramer I; van Deurzen CHM; Heemskerk-Gerritsen BAM; Schaapveld M; Westenend PJ; Voogd AC; Jager A; Steyerberg EW; Sleijfer S; Schmidt MK; Hooning MJ
Cancer Med; 2023 Feb; 12(3):3123-3133. PubMed ID: 36127572
[TBL] [Abstract][Full Text] [Related]
8. Relation of risk of contralateral breast cancer to the interval since the first primary tumour.
Rubino C; Arriagada R; Delaloge S; Lê MG
Br J Cancer; 2010 Jan; 102(1):213-9. PubMed ID: 19920826
[TBL] [Abstract][Full Text] [Related]
9. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk.
Kramer I; Hooning MJ; Mavaddat N; Hauptmann M; Keeman R; Steyerberg EW; Giardiello D; Antoniou AC; Pharoah PDP; Canisius S; Abu-Ful Z; Andrulis IL; Anton-Culver H; Aronson KJ; Augustinsson A; Becher H; Beckmann MW; Behrens S; Benitez J; Bermisheva M; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Brauch H; Bremer M; Brucker SY; Burwinkel B; Castelao JE; Chan TL; Chang-Claude J; Chanock SJ; Chenevix-Trench G; Choi JY; Clarke CL; ; Collée JM; Couch FJ; Cox A; Cross SS; Czene K; Daly MB; Devilee P; Dörk T; Dos-Santos-Silva I; Dunning AM; Dwek M; Eccles DM; Evans DG; Fasching PA; Flyger H; Gago-Dominguez M; García-Closas M; García-Sáenz JA; Giles GG; Goldgar DE; González-Neira A; Haiman CA; Håkansson N; Hamann U; Hartman M; Heemskerk-Gerritsen BAM; Hollestelle A; Hopper JL; Hou MF; Howell A; ; ; Ito H; Jakimovska M; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kets CM; Khusnutdinova E; Ko YD; Kristensen VN; Kurian AW; Kwong A; Lambrechts D; Le Marchand L; Li J; Lindblom A; Lubiński J; Mannermaa A; Manoochehri M; Margolin S; Matsuo K; Mavroudis D; Meindl A; Milne RL; Mulligan AM; Muranen TA; Neuhausen SL; Nevanlinna H; Newman WG; Olshan AF; Olson JE; Olsson H; Park-Simon TW; Peto J; Petridis C; Plaseska-Karanfilska D; Presneau N; Pylkäs K; Radice P; Rennert G; Romero A; Roylance R; Saloustros E; Sawyer EJ; Schmutzler RK; Schwentner L; Scott C; See MH; Shah M; Shen CY; Shu XO; Siesling S; Slager S; Sohn C; Southey MC; Spinelli JJ; Stone J; Tapper WJ; Tengström M; Teo SH; Terry MB; Tollenaar RAEM; Tomlinson I; Troester MA; Vachon CM; van Ongeval C; van Veen EM; Winqvist R; Wolk A; Zheng W; Ziogas A; Easton DF; Hall P; Schmidt MK
Am J Hum Genet; 2020 Nov; 107(5):837-848. PubMed ID: 33022221
[TBL] [Abstract][Full Text] [Related]
10. Prediction and clinical utility of a contralateral breast cancer risk model.
Giardiello D; Steyerberg EW; Hauptmann M; Adank MA; Akdeniz D; Blomqvist C; Bojesen SE; Bolla MK; Brinkhuis M; Chang-Claude J; Czene K; Devilee P; Dunning AM; Easton DF; Eccles DM; Fasching PA; Figueroa J; Flyger H; García-Closas M; Haeberle L; Haiman CA; Hall P; Hamann U; Hopper JL; Jager A; Jakubowska A; Jung A; Keeman R; Kramer I; Lambrechts D; Le Marchand L; Lindblom A; Lubiński J; Manoochehri M; Mariani L; Nevanlinna H; Oldenburg HSA; Pelders S; Pharoah PDP; Shah M; Siesling S; Smit VTHBM; Southey MC; Tapper WJ; Tollenaar RAEM; van den Broek AJ; van Deurzen CHM; van Leeuwen FE; van Ongeval C; Van't Veer LJ; Wang Q; Wendt C; Westenend PJ; Hooning MJ; Schmidt MK
Breast Cancer Res; 2019 Dec; 21(1):144. PubMed ID: 31847907
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Drooger J; Akdeniz D; Pignol JP; Koppert LB; McCool D; Seynaeve CM; Hooning MJ; Jager A
Breast Cancer Res Treat; 2015 Nov; 154(1):171-80. PubMed ID: 26467044
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for contralateral breast cancer in postmenopausal breast cancer survivors in the NIH-AARP Diet and Health Study.
Ramin C; Mullooly M; Schonfeld SJ; Advani PG; Bodelon C; Gierach GL; Berrington de González A
Cancer Causes Control; 2021 Aug; 32(8):803-813. PubMed ID: 33877513
[TBL] [Abstract][Full Text] [Related]
13. Race, ethnicity and risk of second primary contralateral breast cancer in the United States.
Watt GP; John EM; Bandera EV; Malone KE; Lynch CF; Palmer JR; Knight JA; Troester MA; Bernstein JL
Int J Cancer; 2021 Jun; 148(11):2748-2758. PubMed ID: 33544892
[TBL] [Abstract][Full Text] [Related]
14. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
15. Mammographic breast density is associated with the development of contralateral breast cancer.
Raghavendra A; Sinha AK; Le-Petross HT; Garg N; Hsu L; Patangan M; Bevers TB; Shen Y; Banu A; Tripathy D; Bedrosian I; Barcenas CH
Cancer; 2017 Jun; 123(11):1935-1940. PubMed ID: 28135395
[TBL] [Abstract][Full Text] [Related]
16. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.
Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL;
Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391
[TBL] [Abstract][Full Text] [Related]
17. [Contralateral breast cancer: metastasis or second primary cancer?].
Broët P; de la Rochefordière A; Scholl SM; Fourquet A; Mosseri V; Durand JC; Pouillart P; Asselain B
Bull Cancer; 1996 Oct; 83(10):870-6. PubMed ID: 8952638
[TBL] [Abstract][Full Text] [Related]
18. A model for individualized risk prediction of contralateral breast cancer.
Chowdhury M; Euhus D; Onega T; Biswas S; Choudhary PK
Breast Cancer Res Treat; 2017 Jan; 161(1):153-160. PubMed ID: 27815748
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for contralateral breast cancer in Chennai (Madras), India.
Gajalakshmi CK; Shanta V; Hakama M
Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728
[TBL] [Abstract][Full Text] [Related]
20. The Influence of Adjuvant Systemic Regimens on Contralateral Breast Cancer Risk and Receptor Subtype.
Kramer I; Schaapveld M; Oldenburg HSA; Sonke GS; McCool D; van Leeuwen FE; Van de Vijver KK; Russell NS; Linn SC; Siesling S; Menke-van der Houven van Oordt CW; Schmidt MK
J Natl Cancer Inst; 2019 Jul; 111(7):709-718. PubMed ID: 30698719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
